|
Zilucoplan Clinical Trials
2 actively recruiting trials across 2 locations
No change since August 2026
Also known as: RA101495
Pipeline
Phase 3: 1Phase 2/3: 1
Top Sponsors
- UCB Biopharma SRL1
- Miriam Freimer1
Indications
- Cancer2
- Generalized Myasthenia Gravis1
- Generalized Myasthenia Gravis (gMG)1
Tampa, Florida1 trial
Zilucoplan for Severe gMG Exacerbations
University of South Florida/Tampa General Hospital
Phase 3
Chicago, Illinois1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.